CD4+ conventional T cells (C11) and CD8+ cytotoxic T cells (C12) also exhibited an increasing trend.
← all excerpts
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma.
1
—
—
CD4+ conventional T cells (C11) and CD8+ cytotoxic T cells (C12) also exhibited an increasing trend.